Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo

International Journal of Cancer

Volumn 122, Issue 3, 2008, Pages 526-533

  Busch, Christian ^a   Drews, Ulrich ^a   Eisele, Stefan R ^a   Garbe, Claus ^a   Oppitz, Matthias ^a,b,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Landeskrankenhaus Feldkirch ^*  (Austria)

^c Section of Dermatologic Oncology   (Germany)

Author keywords

B16 F1; BMP 2; Chick embryo; Melanoma; Noggin

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; NOGGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER TRANSPLANTATION; CELL AGGREGATION; CELL MIGRATION; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MELANOMA; MELANOMA CELL; MOUSE; NEURAL CREST; NEURAL TUBE; NONHUMAN; OPTIC DISK CUP; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELL AGGREGATION; CELL SURVIVAL; CHICK EMBRYO; EYE; FEMALE; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MELANOMA, EXPERIMENTAL; MICE; NEOPLASM INVASIVENESS; OPTIC DISK; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 37349117695     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23139     Document Type: Article

References (51)

1. Schriek G, Oppitz M, Busch C, Just L, Drews U. Human SK-Mel 28 melanoma cells resume neural crest cell migration after transplantation into the chick embryo. Melanoma Res 2005;15:225-34.
2. Oppitz M, Busch C, Schriek G, Just L, Metzger M, Drews U. Non-malignant migration of B16 mouse melanoma cells in the neural crest and invasive growth in the eye cup of the chick embryo. Melanoma Res 2007;17:17-30.
3. Le Douarin NM, Kalcheim C. The neural crest, 2nd ed. Cambridge: Cambridge University Press, 1999. 469 p
4. Busch C, Oppitz M, Sailer MH, Just L, Metzger M, Drews U. BMP-2 dependent integration of mouse adult subventricular stem cells into the neural crest of chick and quail embryos. J Cell Sci 2006;119:4467-74.
5. Sailer MH, Hazel TG, Panchision DM, Hoeppner DJ, Schwab ME, McKay RD. BMP2 and FGF2 cooperate to induce neural-crest-like fates from fetal and adult CNS stem cells. J Cell Sci 2005;118:5849-60.
6. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 2005;65:448-56.
7. Panchision DM, Pickel JM, Studer L, Lee SH, Turner PA, Hazel TG, McKay RD. Sequential actions of BMP receptors control neural precursor cell production and fate. Genes Dev 2001;15:2094-110.
8. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996;6:432-8.
9. Gobbi G, Sangiorgi L, Lenzi L, Casadei R, Canaider S, Strippoli P, Lucarelli E, Ghedini I, Donati D, Fabbri N, Warzecha J, Yeoung C, et al. Seven BMPs and all their receptors are simultaneously expressed in osteosarcoma cells. Int J Oncol 2002;20:143-7.
10. Hatakeyama S, Ohara-Nemoto Y, Kyakumoto S, Satoh M. Expression of bone morphogenetic protein in human adenocarcinoma cell line. Biochem Biophys Res Commun 1993;190:695-701.
11. Ide H, Yoshida T, Matsumoto N, Aoki K, Osada Y, Sugimura T, Terada M. Growth regulation of human prostate cancer cells by bone morphogenetic protein-2. Cancer Res 1997;57:5022-7.
12. Kleeff J, Maruyama H, Ishiwata T, Sawhney H, Friess H, Buchler MW, Korc M. Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 1999;116:1202-16.
13. Kiyozuka Y, Nakagawa H, Senzaki H, Uemura Y, Adachi S, Teramoto Y, Matsuyama T, Bessho K, Tsubura A. Bone morphogenetic protein-2 and type IV collagen expression in psammoma body forming ovarian cancer. Anticancer Res 2001;21:1723-30.
14. Arnold SF, Tims E, Mcgrath BE. Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. Cytokine 1999;11:1031-7.
15. Langenfeld EM, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumours. Mol Cancer Res 2004;2:141-9.
16. Miyazono K, Ichijo H, Heldin CH. Transforming growth factor-beta: latent forms, binding proteins and receptors. Growth Factors 1993;8:11-22.
17. Allendorph GP, Vale WW, Choe S. Structure of the ternary signaling complex of a TGF-β superfamily member. Proc Natl Acad Sci USA 2006;103:7643-8.
18. Hsu MY, Rovinsky S, Penmatcha S, Herlyn M, Muirhead D. Bone morphogenic proteins in melanoma: angel or devil? Cancer Met Rev 2005;24:251-63.
19. Zhu W, Kim J, Cheng C, Rawlins BA, Boachie-Adjei O, Crystal RG, Hidaka C. Noggin regulation of bone morphogenetic protein (BMP) 2/7 heterodimer activity in vitro. Bone 2006;39:61-71.
20. Zimmermann LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606.
21. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.
22. Smith WC, Harland RM. Expression cloning of noggin, a new dorsalizing factor localized to the Spermann organizer in Xenopus embryos. Cell 1992;70:829-40.
23. Sela-Donenfeld D, Kalcheim C. Regulation of the onset of neural crest migration by coordinated activity of BMP4 and noggin in the dorsal neural tube. Development 1999;126:4749-62.
24. Brunet LJ, McMahon JA, McMahon AP, Harland RM. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 1998;280:1455-7.
25. Nakamura Y, Nakaya H, Saito N, Wakitani S. Coordinate expression of BMP-2, BMP receptors and noggin in normal mouse spine. J Clin Neurosci 2006;13:250-6.
26. Valenzuela DM, Economides AN, Rojas E, Lamb TM, Nunez L, Jones P, Lp NY, Espinosa R, III, Brannan CI, Gilbert DJ, Copeland NG, Jenkins NA, et al. Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci 1995;15:6077-84.
27. Fidler IJ. Biological behaviour of malignant melanoma cells correlated to their survival in vivo. Cancer Res 1975;35:218-24.
28. Carl UD, Pollmann M, Orr E, Gertler FB, Chakraborty T, Wehland J. Aromatic and basic residues within the EVH1 domain of VASP specify its interaction with proline-rich ligands. Curr Biol 1999;9:715-8.
29. Rottner K, Behrend B, Small JV, Wehland J. VASP dynamics during lamellipodia protrusion. Nature Cell Biol 1999;1:321-2.
30. Hatano H, Tokunaga K, Ogose A, Hotta T, Yamagiwa H, Hayami T, Endo N, Takahashi HE. Origin of bone-forming cells in human osteosarcomas transplanted into nude mice - which cells produce bone, human or mouse? J Pathol 1998;185:204-11.
31. Taatjes DJ, Arendash-Durand B, von Turkovich D, Trainer TD. HMB-45 antibody demonstrates melanosome specificity by immunoelectron microscopy. Arch Pathol Lab Med 1993;117:264-8.
32. Drews U, Ebensperger C, Wolf U. An in vitro model of gonad differentiation in the chick embryo. Roller cultures in gas permeable biofoil bags. Anat Embryol 1988;178:529-36.
33. Hamburger V, Hamilton HL. A series of normal stages in the development of the chick embryo (1951). Dev Dyn 1992;195:231-72.
34. Just L, Timmer M, Tinius J, Stahl F, Deiwick A, Nikkhah G, Bader A. Identification of human cells in brain xenografte and in neural cocultures of rat by in situ hybridization with Alu probe. J Neurosci Methods 2003;126:69-77.
35. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumour progression. Curr Opin Cell Biol 2005;17:548-58.
36. Kulesa PM, Kasemeier-Kulesa JC, Teddy JM, Margaryan NV, Seftor EA, Seftor REB, Hendrix MJC. Reprogramming metastatic melanoma cells to assume a neural crest cell-like phenotype in an embryonic microenvironment. Proc Natl Acad Sci USA 2006;103:3752-7.
37. Erickson CA, Tosney KW, Weston JA. Analysis of migratory behaviour of neural crest and fibroblastic cells in embryonic tissues. Dev Biol 1980;77:142-56.
38. Luyten GPM, Mooy CM, de Jong PTVM, Hoogeveen AT, Luider TM. A chicken embryo model to study the growth of human uveal melanoma. Biochem Biophys Res Commun 1993;192:22-9.
39. Searle EA, Austin LM, Biossy YL, Zhao H, Nordlund JJ, Boissy RE. Smyth chicken melanocyte autoantibodies: cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum. Pigment Cell Res 1993;6:145-57.
40. Goldstein AM, Brewer KC, Doyle AM, Nagy N, Roberts DJ. BMP signaling is necessary for neural crest cell migration and ganglion formation in the enteric nervous system. Mech Dev 2005;122:821-33.
41. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005;233:706-20.
42. Newgreen DF, Minichiello J. Control of epitheliomesenchymal transformation. I. Events in the onset of neural crest cell migration are separable and inducible by protein kinase inhibitors. Dev Biol 1995;170:91-101.
43. 2+-dependent cell adhesions. Cell Tissue Res 1985;239:329-39.
44. Duband JL, Monier F, Delannet M, Newgreen D. Epithelium-mesenchyme transition during neural crest development. Acta Anat (Basel) 1995;154:63-78.
45. Akitaya T, Bronner-Fraser M. Expression of cell adhesion molecules during initiation and cessation of neural crest cell migration. Dev Dyn 1992;194:12-20.
46. Shoval I, Ludwig A, Kalcheim C. Antagonistic roles of full-length N-cadherin and its soluble BMP cleavage product in neural crest delamination. Development 2007;134:491-501.
47. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung MC. Dual regulation of snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004;6:931-40.
48. Kuphal S, Bosserhoff AK. Influence of the cytoplasmic domain of E-cadheirn on endogenous N-cadherin expression in malignant melanoma. Oncogene 2006;25:248-59.
49. Alonso SR, Tracey L, Ortiz P, Pérez-Gómez B, Palacios J, Pollán M, Linares J, Serrano S, Sáez-Castillo A, Sánchez L, Pajares R, Sánchez-Aguilera A, et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res 2007;67:3450-60.
50. Gupta PB, Kuperwasser C, Brunet J-P, Ramaswamy S, Kuo W-L, Gray JW, Naber SP, Weinberg RA. The melanocyte differentiation program predidposes to metastasis after neoplastic transformation. Nat Genet 2005;37:1047-54.
51. Dissanayake SK, Wade MW, Johnson CE, O'Connell MP, Leotlela PD, French AD, Shah KV, Hewitt KJ, Rosenthal DT, Indig FE, Jiang Y, Nickoloff BJ, et al. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. J Biol Chem 2007;202:17259-71.